Press Releases
- Real-World Study Comparing Commonly Prescribed COPD Medicines Shows Choice of Treatment Has Impact on Patient Outcomes
- 19 March 2013
- AstraZeneca Donates $225,000 to Support Heart Disease Research
- 8 March 2013
- Mood app designed for youth by youth launches today at Sandbox Conference
- 17 January 2013
- Creation of the NĒOMED Institute: renewing biopharmaceutical research in Québec
- 23 November 2012
- New survey reveals significant gender gap in post-heart attack health care
- 13 March 2012
- Impact of Osteoarthritis Felt Beyond Pain: New Survey Finds GI Complications Associated with Medication and Impact on Workplace Also Significant
- 20 September 2011
- This fall, take the ouch out of flu vaccination
- 11 September 2011
- Health Canada approves new treatment that reduces the risk of cardiovascular death more than current standard of care
- 1 June 2011
- Health Canada Approves VIMOVO, the First NSAID-PPI Combination to Treat Osteoarthritis Pain and Inflammation While Reducing the Risk of NSAID- associated Ulcers
- 27 April 2011
- First nasal vaccine approved in Canada to prevent seasonal influenza
- 14 July 2010
- AstraZeneca and McGill partner on pain research
- 30 June 2010
- Targeted Approach Represents Paradigm Shift In The Diagnosis And Treatment Of Non-Small Cell Lung Cancer (NSCLC)
- 16 March 2010
- Astrazeneca Invests $1.2 Million In Support Of Cancer Research In British Columbia
- 4 March 2010
- Health Canada Approves Symbicort® Turbuhaler® for chronic obstructive pulmonary disease – increasing patients' quality of life and reducing exacerbations
- 14 January 2010
- The Healthcare You Don’t Hear About
- 30 November 2009
- Photojournalists Capture Powerful Realities of “Frontlines” Care
- 30 September 2009
- National Diabetes Strategy Receives Financial Boost
- 2 September 2009
- University of Saskatchewan College of Pharmacy and Nutrition Teams up with Government and Industry to Address Patient Adherence
- 15 June 2009
- AstraZeneca Canada partners with Université Laval
- 20 March 2009
- Crestor Cuts Risk Of Stroke By Nearly Half In Jupiter Study
- 19 February 2009
- AstraZeneca Canada Partners With University Of Waterloo, School Of Pharmacy
- 1 January 2009
- Study Uncovers Overlooked Risk Factor That May Be Key To Saving Canadians From First Heart Attacks And Strokes
- 9 November 2008
- Excellence in Chemistry Earns UBC Prof. $100,000 Award
- 18 September 2008
- Québec Government, AstraZeneca, Pfizer Canada and Merck Frosst Team Up to Stimulate Pharmaceutical Research and Accelerate Drug Discovery
- 17 June 2008
- Chronic pain research and treatment in Quebec gets $4.35-million boost from Pfizer, AstraZeneca, MSSS and FRSQ
- 28 February 2008
- AstraZeneca Canada Ranks #2 on Canada's 30 Best Pension and Benefit Plans List for 2008
- 1 January 2008
- Défi-Santé 5/30
- 1 January 2008
- A New Approach To Asthma Treatment Approved by Health Canada
- 6 March 2007
- Quebec Life Sciences Research Sector Gets $10 Million Boost
- 2 February 2007
Executive Biographies
Key Facts
Find out more about our Key Facts
Media Contacts
If you are a member of the media and have an inquiry, please call (905) 277-7111 or 1-800-565-5877 and ask to speak to a member of the Corporate Communications team. You may also send an email to CanadianMediaInquiries@astrazeneca.com.
For further information, please review our Privacy Policy.